Skip to content

Rachel Elizabeth Ohman, MD

NPI 1912467135ActiveIndividual· Internal Medicine· Los Angeles, CA

Internal Medicine (MD) in Los Angeles, California, licensed in CA, with an NPI issued in March 2019. Part D covered 73 prescriptions written in 2024, 82% of them generic. Abbott Laboratories was the largest of 3 companies reporting payments in 2025, $534.66 in all, mostly education.

Overview

NPI1912467135
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedMar 22, 2019
Last updated in NPPESOct 29, 2026
Certified by providerOct 29, 2026

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine Primary207R00000XA177623CA

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)73 · 209 30-day fills
Patients16
Total drug cost$4,791
Generic share82% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$534.66 · 4 payments from 3 companies

Top paying companies in 2025

CompanyAmountPayments
Abbott Laboratories$276.851
Endotronix, Inc.$222.812
Pfizer Inc.$35.001

What the 2025 payments were for

  • Education$276.85 · 1 payment
  • Food and Beverage$257.81 · 3 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine providers in Los Angeles

All Internal Medicine providers in California →